# Prospective, Non-randomized, Safety and Efficacy Study of a New Occluder Design for Minimally Invasive Closure of the Left Atrial Appendage (LAA) in Patients With Atrial Fibrillation

> **NCT02105584** · NA · COMPLETED · sponsor: **Occlutech International AB** · enrollment: 78 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DEVICE:** Implantation of LAA closure device

## Key facts

- **NCT ID:** NCT02105584
- **Lead sponsor:** Occlutech International AB
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2017-09
- **Final completion:** 2017-09
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2018-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02105584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02105584, "Prospective, Non-randomized, Safety and Efficacy Study of a New Occluder Design for Minimally Invasive Closure of the Left Atrial Appendage (LAA) in Patients With Atrial Fibrillation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02105584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*